SKU: BROMOSTAR-T-5ML
Bromostar T Eye Drop 5ML is a prescription ophthalmic medicine containing Brimonidine 0.2% and Timolol 0.5%. It helps reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
The combination works by reducing the production of fluid inside the eye and improving its drainage. Regular use, as prescribed by an ophthalmologist, helps manage eye pressure and reduce the risk of glaucoma-related optic nerve damage.
Bromostar-T Eye Drop 5ML is a prescription ophthalmic medicine containing Brimonidine 0.2% w/v and Timolol 0.5% w/v. It is used to reduce increased pressure inside the eye in conditions such as open-angle glaucoma and ocular hypertension. By helping lower intraocular pressure, the medicine can help reduce the risk of pressure-related damage to the optic nerve.
Bromostar-T combines two medicines that lower eye pressure through different mechanisms. Brimonidine helps reduce the production of aqueous humour and promotes its outflow, while Timolol reduces aqueous humour production. This combined action helps provide better control of elevated intraocular pressure in appropriate patients.
Bromostar-T Eye Drop is manufactured/marketed by Mankind Pharmaceuticals Ltd. and is supplied as a 5 mL ophthalmic eye-drop preparation. It should be used only according to the prescription and instructions provided by an eye-care professional.
Bromostar-T Eye Drop is primarily prescribed for conditions associated with increased pressure inside the eye. High intraocular pressure can place stress on the optic nerve and, if left untreated, may contribute to progressive vision loss.
The medicine does not reverse existing optic nerve damage. Its purpose is to help control eye pressure and reduce the risk of further damage when used as prescribed.
Bromostar-T contains two pressure-lowering medicines that work through complementary mechanisms. This helps reduce the amount of aqueous humour in the eye and consequently lowers intraocular pressure.
Maintaining appropriate intraocular pressure is an important part of glaucoma management. Regular use as prescribed can help control eye pressure and reduce the risk of progressive optic nerve damage.
The combination of Brimonidine and Timolol provides two different mechanisms of action in one eye-drop formulation. This may be useful when a single pressure-lowering medicine does not provide adequate control.
Ocular hypertension refers to higher-than-normal pressure inside the eye without necessarily having established glaucoma. Your ophthalmologist can determine whether pressure-lowering treatment is appropriate based on your eye examination and individual risk factors.
Brimonidine is an alpha-2 adrenergic receptor agonist used in ophthalmic medicines to reduce intraocular pressure. It decreases aqueous humour production and also supports aqueous humour outflow, helping lower pressure within the eye.
Timolol is a beta-adrenergic blocker used in ophthalmology to reduce aqueous humour production. By decreasing fluid production inside the eye, Timolol contributes to lowering intraocular pressure.
Some versions of Bromostar-T may contain preservatives depending on the specific formulation. Always check the current product packaging for the complete composition and excipient information.
The eye continuously produces a clear fluid called aqueous humour. This fluid normally circulates through the eye and drains through natural pathways. When production and drainage are not properly balanced, pressure inside the eye can increase.
Brimonidine helps reduce aqueous humour production and can increase its drainage. Timolol primarily reduces the production of aqueous humour. By combining these actions, Bromostar-T helps lower elevated intraocular pressure.
Controlling intraocular pressure is particularly important in glaucoma because prolonged elevated pressure may contribute to optic nerve damage and gradual loss of vision.
Use Bromostar-T exactly as prescribed by your ophthalmologist. Do not change the number of drops or frequency of administration without medical advice.
If you use more than one eye medication, maintain the interval recommended by your doctor, generally at least 5–10 minutes between different eye drops. Eye ointments are usually applied after eye drops.
The appropriate dose and frequency depend on the severity of the condition, response to treatment, and other medicines being used. Follow the exact dosing schedule prescribed by your ophthalmologist.
Bromostar-T should not be used more frequently or in larger amounts than prescribed. Consistent use is important in long-term glaucoma treatment because pressure may increase again if treatment is interrupted.
Do not stop the medicine simply because your eyes feel normal. Glaucoma and ocular hypertension may not cause noticeable symptoms in the early stages.
Some patients may experience mild and temporary effects after applying Bromostar-T. These effects may improve as the eyes adjust to treatment.
Contact your doctor if side effects are severe, persistent, or become worse. Seek urgent medical attention for severe eye pain, sudden changes in vision, significant swelling, breathing difficulty, fainting, or other serious symptoms.
Bromostar-T is a prescription medicine and should be used under appropriate ophthalmic supervision. Because Timolol can have effects beyond the eye after systemic absorption, certain medical conditions require particular caution.
Inform your doctor about all medicines you are currently taking, particularly medicines for blood pressure, heart conditions, glaucoma, or depression.
If your formulation contains a preservative, contact lenses may need to be removed before applying the eye drops because some preservatives can be absorbed by soft contact lenses.
Follow the instructions supplied with your specific product and ask your ophthalmologist or pharmacist when it is appropriate to reinsert contact lenses after application.
If you are pregnant, planning pregnancy, or breastfeeding, inform your doctor before using Bromostar-T. Your healthcare professional will assess whether the expected benefits of treatment outweigh potential risks and will determine the most appropriate treatment for your condition.
Do not start or stop glaucoma treatment during pregnancy or breastfeeding without medical guidance.
Temporary blurred vision or other visual disturbances may occur after applying eye drops. Avoid driving or operating machinery until your vision becomes clear and you are confident that the medicine does not affect your ability to drive safely.
If you miss a scheduled dose, use it when you remember unless it is almost time for your next scheduled dose. If the next dose is near, skip the missed dose and continue with your regular schedule.
Do not use a double dose to compensate for a missed application. If you frequently forget doses, discuss practical reminders with your healthcare professional.
Store Bromostar-T according to the current product label. Available product information recommends storage below 30°C and protection from unsuitable environmental conditions.
If your ophthalmologist has prescribed multiple eye medicines, it is important to follow the correct sequence and maintain the recommended interval between applications.
Using several eye medicines too close together can wash one medicine out before it has sufficient time to act. Generally, a gap of several minutes is recommended between different eye drops, but follow the specific instructions provided by your doctor.
For additional information about ophthalmic products, explore the BuyCenforce Eye Care Category.
Glaucoma is often a long-term condition that requires regular monitoring. Elevated eye pressure may occur without obvious symptoms, which is why scheduled eye examinations are important even when vision appears normal.
Bromostar-T may help control intraocular pressure when prescribed appropriately, but it does not eliminate the need for regular ophthalmic examinations. Your doctor may monitor eye pressure, optic nerve health, visual fields, and other parameters to evaluate treatment effectiveness.
Patients can also explore the BuyCenforce Health Blog for additional general healthcare and medicine-related educational information.
For additional ophthalmic medicines and eye-care products, visit the BuyCenforce Eye Care Category.
For information about other prescription healthcare products, explore the BuyCenforce Health Blog.
For additional medicine-related healthcare information, you can also explore the BuyCenforce Respiratory Care Category.
Bromostar-T Eye Drop is a prescription ophthalmic medicine containing Brimonidine 0.2% w/v and Timolol 0.5% w/v. It is used to lower elevated pressure inside the eye.
It is used for the management of ocular hypertension and open-angle glaucoma, where reducing intraocular pressure is an important part of treatment.
Brimonidine and Timolol reduce aqueous humour production through different mechanisms. Brimonidine also promotes aqueous humour outflow, helping lower pressure inside the eye.
Yes. Bromostar-T is a prescription eye medicine and should be used according to an ophthalmologist's instructions.
No. Do not stop glaucoma or ocular-hypertension treatment without consulting your ophthalmologist. Elevated eye pressure may not produce noticeable symptoms even when treatment is needed.
It may be possible to use Bromostar-T with other ophthalmic medicines when prescribed by your doctor. Maintain the recommended interval between different eye drops and follow your ophthalmologist's instructions.
Temporary blurred vision may occur after application. Avoid driving until your vision is clear. Contact your doctor if blurred vision persists or is severe.
Timolol is a beta-blocker, so Bromostar-T may not be appropriate for people with asthma or certain severe respiratory conditions. Tell your doctor about any history of asthma or breathing problems before treatment.
Use the missed dose when remembered unless it is close to the next scheduled dose. In that situation, skip the missed dose and continue with the regular schedule. Do not double the dose.
Store the product according to its current label, generally below 30°C, protected from direct sunlight and excessive heat. Keep the bottle closed and do not freeze it.
This information is provided for general educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Bromostar-T Eye Drop is a prescription medicine. Always follow your ophthalmologist's instructions and check the current product packaging for the exact formulation, dosage, storage conditions, and directions for use.
| Brand | Bromostar |
| Manufacturer | |
| Composition | |
| Package | |
| Ship time |
Free Shipping
For all oders over $99
Secure Payment
100% secure payment
24/7 Support
Online top support